Table 1

HSV type 2 seroprevalence in antenatal clinic attendees

City and country	Number tested	Percentage positive	Test	Reference
NK = not known; ELISA = enzyme immunoassay; gG2 = glycoprotein G2; WB = western blot.
*Not type specific.
†Year not stated.
Tokyo Japan 1988	90	6.7	gG2 Immunoblot	30
Padua Italy 1985–6	NK	8.4	gG2 Immunoblot	12
Seville Spain 1985–6	NK	9.7	gG2 Immunoblot	12
London England 1980–1	3553	10	ELISA*	31
Birmingham Alabama USA (whites, private practice) 1985	NK	11.4	gG2 Immunoblot	12
Sydney Australia 1995–8	2616	12.5	gG2 ELISA/WB	Present study
Taiwan 1986–7	NK	13.5	gG2 Immunoblot	12
Sydney, Australia 1984–5	229	14.5	gG2 ELISA	11
Helsinki, Finland 1988–9	997	16.0	gG2 ELISA	24
Stanford USA†	1580	16.5	gG2 ELISA	13
Stockholm, Sweden 1969	941	17	gG2 ELISA	23
Lyons, France 1986	NK	17.3	gG2 Immunodot	12
Reykjavik, Iceland 1985	NK	18.8	gG2 ELISA	12
Malmo, Sweden 1970–3	941	21	gG2 ELISA	32
Malmo, Sweden 1987	294	21	gG2 ELISA	32
Malmo, Sweden 1990–1	1190	21	gG2 ELISA	32
Malmo, Sweden 1986–9	562	25	gG2 ELISA	32
Seattle, USA 1989–93	8538	28.5	WB	6
Stockholm, Sweden 1983	1759	32	gG2 ELISA	23
Stockholm, Sweden 1989	1000	32	gG2 ELISA	23
Stanford, USA 1991	277	32	gG2 ELISA	19
Los Angeles, USA 1985–8	1355	32	WB	14
Atlanta, USA (whites) 1984–5	NK	34.9	gG2 Immunoblot	12
Sao Paulo Brazil (low and middle class) 1988–9	455	36	ELISA and WB	33
Seattle, USA 1990	201	37.8	WB	15
Sao Paulo, Brazil (very low income) 1988–9	200	42	ELISA and WB	33
Atlanta, USA (blacks) 1984–5	NK	53.4	gG2 Immunoblot	12